In lung cancer, CD4+ T cells present intracellular C3 cleavage by cathepsin and C3a signaling inhibits the production of multiple cytokines by CD4+ T cells, independently of FOXP3+ Tregs (51) (Figure 4). The gene discussed is CD4; the disease is lung cancer.